DaVita Stock Outlook: Is Wall Street Bullish or Bearish?

DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $11 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. 

Shares of this kidney care giant have underperformed the broader market over the past year. DVA has gained 5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 11.9%. In 2025, DVA stock is down 3.4%, compared to the SPX’s marginal decline on a YTD basis.